Form 4 for CDNA CareDx, Inc.
Accepted 2021-09-07 00:00:00 ET · period of report 2021-09-07 · accession 0001217234-21-000210 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-07 | 2021-09-07 | CDNA | Maag Peter | Executive COB, Dir | S - Sale+OE | $73.67 | -10.0K | 342.1K | -3% | -$736.7K |
| DM | 2021-09-07 | 2021-09-07 | CDNA | Maag Peter | Executive COB, Dir | M - OptEx | $10.65 | +3,448 | 349.2K | +1.0% | +$36.7K |
| DM | 2021-09-07 | 2021-09-07 | CDNA | Maag Peter | Executive COB, Dir | M - OptEx | $10.65 | +3,448 | 28.7K | +14% | +$36.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | S | D | 300 | $75.31 | 341,756 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.25 to $75.38, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Common Stock | 2021-09-07 | S | D | 8,800 | $73.55 | 342,956 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.10 to $74.055, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 3 | Common | Common Stock | 2021-09-07 | M | A | 2,523 | $12.24 | 351,756 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-07 | M | A | 925 | $6.31 | 349,233 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-07 | S | D | 900 | $74.32 | 342,056 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.13 to $74.43, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-09-07 | M | A | 925 | $6.31 | 9,867 | D | $6.31 · — to 2028-01-19 | 925 Common Stock | (F6) 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2021-09-07 | M | A | 2,523 | $12.24 | 28,727 | D | $12.24 · — to 2028-06-29 | 2,523 Common Stock | (F7) 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |